AbCellera Biologics Inc. logo

AbCellera Biologics Inc. (ABCL)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
6. 46
+0.3
+4.9513%
Pre Market
$
6. 45
-0.01 -0.232%
2.06B Market Cap
- P/E Ratio
- Div Yield
4.23M Volume
-0.47 Eps
$ 6.16
Previous Close
Analysts:
Add Transaction
Day Range
5.93 6.55
Year Range
2.75 8.44
Want to track ABCL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
7 May 2026
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
24 Feb 2026
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
3 Nov 2025
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
12 Aug 2025
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
5 May 2025
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
18 Feb 2025
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
31 Oct 2024
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
1 Aug 2024
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
13 Jun 2024
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
20 Feb 2024
-
-
AbCellera Biologics Inc. logo
ABCL AbCellera Biologics Inc.
2 Nov 2023
-
-

ABCL Earnings Reports FAQ

What is the earnings per share (EPS) for ABCL?

The current EPS is -0.47.

What is the company's earnings growth rate?

AbCellera Biologics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

AbCellera Biologics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for AbCellera Biologics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ABCL at this time, as AbCellera Biologics Inc has no recent EPS data to calculate it.